Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Amgen Slips Even After Earnings and Revenue Beat Estimates
By Rob Daniel
Feb 2, 2021 5:44 PM EST
INVESTING
Amgen Slips Even After Earnings and Revenue Beat Estimates
By Rob Daniel
Feb 2, 2021 5:44 PM EST
MARKETS
GameStop, Amazon, Google, Alibaba and Stimulus - 5 Things You Must Know Tuesday
By Joseph Woelfel
Feb 2, 2021 8:37 AM EST
MARKETS
Silver, GameStop, Robinhood, Amazon, Exxon and Chevron - 5 Things You Must Know Monday
By Joseph Woelfel
Feb 1, 2021 8:06 AM EST
PRESS RELEASES
Amgen Announces Breakthrough Therapy Designation Granted For Sotorasib In China
By PR Newswire
Jan 29, 2021 4:00 PM EST
PRESS RELEASES
Amgen Announces Webcast Of 2020 Fourth Quarter And Full Year Financial Results
By PR Newswire
Jan 28, 2021 4:00 PM EST
PRESS RELEASES
Amgen's Investigational KRAS G12C Inhibitor Sotorasib Demonstrated Rapid, Deep And Durable Responses In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
By PR Newswire
Jan 28, 2021 2:35 PM EST
PRESS RELEASES
Amgen To Webcast Investor Meeting At 2020 World Conference On Lung Cancer
By PR Newswire
Jan 26, 2021 4:00 PM EST
PRESS RELEASES
Amgen To Showcase Next Frontier Of Innovation In Lung Cancer Therapies At WCLC 2020
By PR Newswire
Jan 12, 2021 9:00 AM EST
PRESS RELEASES
Amgen To Achieve Carbon Neutrality By 2027
By PR Newswire
Jan 11, 2021 4:45 PM EST
PRESS RELEASES
Amgen To Present At The 39th Annual J.P. Morgan Healthcare Conference
By PR Newswire
Jan 6, 2021 4:00 PM EST
INVESTING
Stocks Give Up Gains, Close Lower After Relief Optimism Wilts
By Rob Lenihan
Dec 29, 2020 4:20 PM EST
PRESS RELEASES
Amgen Licenses AMG 634, An Investigational Treatment For Tuberculosis And Leprosy, To Medicines Development For Global Health
By PR Newswire
Dec 22, 2020 4:00 PM EST
INVESTING
5 Worst Stocks in the Dow on Tuesday: Walgreens Slips
By Vidhi Choudhary
Dec 22, 2020 4:41 PM EST
INVESTING
7 Worst Stocks in the Nasdaq on Tuesday: Moderna Slides
By Fatma Khaled
Dec 22, 2020 6:57 PM EST
PRESS RELEASES
Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma
By PR Newswire
Dec 22, 2020 2:00 AM EST
PRESS RELEASES
Amgen Awards Two Local Biotech Start-Ups With Golden Ticket To LabCentral
By PR Newswire
Dec 17, 2020 4:10 PM EST
PRESS RELEASES
Amgen Submits Sotorasib New Drug Application To U.S. FDA For Advanced Or Metastatic Non-Small Cell Lung Cancer With KRAS G12C Mutation
By PR Newswire
Dec 16, 2020 4:00 PM EST
PRESS RELEASES
Amgen To Present First Clinical Data For BCMA-Targeted Half-Life Extended BiTEĀ® Therapy AMG 701 At ASH 2020
By PR Newswire
Dec 5, 2020 3:00 PM EST
PRESS RELEASES
Amgen And McKesson Launch Strategic Agreement To Advance Cancer Innovation In Communities
By Business Wire
Dec 4, 2020 7:15 AM EST
PRESS RELEASES
Amgen To Webcast Investor Call At ASH 2020
By PR Newswire
Dec 3, 2020 4:00 PM EST
PRESS RELEASES
World's Leading Life Science Companies Now Enrolling COMMUNITY, A Global, Platform Trial For Hospitalized Patients With COVID-19
By PR Newswire
Nov 30, 2020 4:45 PM EST
PRESS RELEASES
Amgen To Present At The Evercore ISI Virtual HealthCONx Conference
By PR Newswire
Nov 25, 2020 4:00 PM EST
PRESS RELEASES
Amgen To Present At The Jefferies Virtual London Healthcare Conference
By PR Newswire
Nov 13, 2020 4:00 PM EST
PRESS RELEASES
Amgen To Present At The Cowen 4th Annual IO Summit
By PR Newswire
Nov 10, 2020 4:00 PM EST